RAB3GAP1
protein-codingRAB3 GTPase activating protein catalytic subunit 1
Gene summary
This gene encodes the catalytic subunit of a Rab GTPase activating protein. The encoded protein forms a heterodimer with a non-catalytic subunit to specifically regulate the activity of members of the Rab3 subfamily of small G proteins. This protein mediates the hydrolysis of GTP bound Rab3 to the GDP bound form. Mutations in this gene are associated with Warburg micro syndrome. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Feb 2010]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~124.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0008929
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0016649
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0016649
Submitter: ClinGen
RAB3GAP1 was reported in relation to Warburg Micro Syndrome in 2005 (PMID: 15696165). Evidence supporting this gene-disease relationship is largely case-level data. Variants in this gene have been reported across many publications (PMID: 25326635, 20512159, 23420520, 26421802). More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) was reached. However, functional assays have not been done for this gene and would provide an area of interest for future publication. The mechanism for disease is loss of function. In summary, RAB3GAP1 is definitively associated with Warburg Micro Syndrome.
Inheritance Pattern: AR
Disease ID:MONDO:0010822
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0016649
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0010822
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Endocrine; Genitourinary; Musculoskeletal; Neurologic; Ophthalmologic
Intervention: Endocrine; Ophthalmologic; Pharmacogenomic
Rationale: The condition can include a risk of glaucoma, and early treatment may be beneficial; Medical care related to endocrine manifestations may be indicated; Agents that may contribute to glaucoma should be avoided
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to RAB3GAP1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_012233.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 11 | 76 | 4 | 91 | ||
| missense | 2 | 1 | 210 | 16 | 3 | 232 |
| nonsense | 24 | 8 | 1 | 33 | ||
| start loss | 0 | |||||
| frameshift | 18 | 15 | 1 | 34 | ||
| splice donor/acceptor (+/-2bp) | 9 | 10 | 11 | 30 | ||
| Total | 53 | 34 | 234 | 92 | 7 | 420 |
Highest pathogenic variant AF is 0.000029136807
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_036365.1 | 24 | MANE Select | |
| Ensembl | ENSP00000264158.8 | 24 | MANE Select | |
| RefSeq | NP_001165906.1 | 25 | Standard | |
| Ensembl | ENSP00000400761.1 | 3 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Vesicle-mediated transport
- Membrane Trafficking
- Rab regulation of trafficking
- COPI-independent Golgi-to-ER retrograde traffic
- Golgi-to-ER retrograde transport
Biological Process
- brain development
- positive regulation of gene expression
- hypothalamus development
- lipid droplet organization
- camera-type eye development
Molecular Function
- guanyl-nucleotide exchange factor activity
- GTPase activator activity
- protein binding
- Rab guanyl-nucleotide exchange factor activity
- Rab GTPase binding
Cellular Component
- endoplasmic reticulum membrane
- Golgi apparatus
- lipid droplet
- cytosol
- protein-containing complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000442034
- Coding exons
- 25
- Length
- 124130
- Individuals with no LoFs
- 125652
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 96
- Defined
- 125748
- p
- 0.000382
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.18 | 440 | 516 | 0.853 | 0.0000269 | 6458 |
| Missense (PolyPhen) | 114 | 146.23 | 0.77959 | 1693 | ||
| Synonymous | 0.266 | 177 | 182 | 0.975 | 0.00000928 | 1877 |
| Loss of Function | 4.50 | 23 | 60.9 | 0.378 | 0.00000336 | 714 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00055 | 0.00055 | rare |
| Latino/Admixed American | 0.00029 | 0.00029 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.00027 | 0.00027 | rare |
| Finnish | 0.00074 | 0.00074 | rare |
| European (Non-Finnish) | 0.00041 | 0.00040 | rare |
| South Asian | 0.00029 | 0.00029 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Probable catalytic subunit of a GTPase activating protein that has specificity for Rab3 subfamily (RAB3A, RAB3B, RAB3C and RAB3D). Rab3 proteins are involved in regulated exocytosis of neurotransmitters and hormones. Specifically converts active Rab3-GTP to the inactive form Rab3-GDP. Required for normal eye and brain development. May participate in neurodevelopmental processes such as proliferation, migration and differentiation before synapse formation, and non-synaptic vesicular release of neurotransmitters. {ECO:0000269|PubMed:10859313, ECO:0000269|PubMed:9030515}.;
Recessive Scores
- pRec
- 0.149
Intolerance Scores
- LoFtool
- 0.941
- RVIS EVS
- 0.2
- RVIS percentile EVS
- 67.43
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.673
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |